SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

QuidelOrtho Corp. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Thursday, 2/29/24, at 3:29pm ET   ·   For:  12/31/23   ·   Accession #:  1906324-24-11   ·   File #:  1-41409

Previous ‘10-K’:  ‘10-K’ on 2/23/23 for 1/1/23   ·   Latest ‘10-K’:  This Filing   ·   14 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/29/24  QuidelOrtho Corp.                 10-K       12/31/23  127:14M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.54M 
 2: EX-10.19    Material Contract                                   HTML     59K 
 3: EX-10.20    Material Contract                                   HTML     73K 
 4: EX-21.1     Subsidiaries List                                   HTML     49K 
 5: EX-23.1     Consent of Expert or Counsel                        HTML     34K 
 9: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     42K 
                Awarded Compensation                                             
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
15: R1          Cover Page                                          HTML     99K 
16: R2          Audit Information                                   HTML     39K 
17: R3          Consolidated Balance Sheets                         HTML    147K 
18: R4          Consolidated Balance Sheets (Parenthetical)         HTML     54K 
19: R5          Consolidated Statements of Income                   HTML    106K 
20: R6          Consolidated Statements of Comprehensive Income     HTML     68K 
                (Loss)                                                           
21: R7          Consolidated Statements of Stockholders' Equity     HTML     98K 
                Statement                                                        
22: R8          Consolidated Statements of Cash Flows               HTML    144K 
23: R9          Summary of Significant Accounting Policies          HTML     81K 
24: R10         Business Combination                                HTML     94K 
25: R11         Computation of Earnings Per Share                   HTML     50K 
26: R12         Revenue                                             HTML     64K 
27: R13         Segment and Geographic Information                  HTML     98K 
28: R14         Income Taxes                                        HTML    137K 
29: R15         Balance Sheet Account Details                       HTML    203K 
30: R16         Borrowings                                          HTML     71K 
31: R17         Leases                                              HTML     53K 
32: R18         Stockholders' Equity                                HTML     49K 
33: R19         Stock-Based Compensation                            HTML     86K 
34: R20         Commitments and Contingencies                       HTML     40K 
35: R21         Fair Value Measurements                             HTML     83K 
36: R22         Derivative Instruments and Hedging Activities       HTML     88K 
37: R23         Long-term Employee Benefits                         HTML    177K 
38: R24         Related Party Transactions                          HTML     40K 
39: R25         Accumulated Other Comprehensive (Loss) Income       HTML     65K 
40: R26         Pay vs Performance Disclosure                       HTML     46K 
41: R27         Insider Trading Arrangements                        HTML     40K 
42: R28         Summary of Significant Accounting Policies          HTML    144K 
                (Policies)                                                       
43: R29         Business Combination (Tables)                       HTML     93K 
44: R30         Computation of Earnings Per Share (Tables)          HTML     48K 
45: R31         Revenue (Tables)                                    HTML     57K 
46: R32         Segment and Geographic Information (Tables)         HTML     99K 
47: R33         Income Taxes (Tables)                               HTML    139K 
48: R34         Balance Sheet Account Details (Tables)              HTML    221K 
49: R35         Borrowings (Tables)                                 HTML     70K 
50: R36         Leases (Tables)                                     HTML     54K 
51: R37         Stock-Based Compensation (Tables)                   HTML     87K 
52: R38         Fair Value Measurements (Tables)                    HTML     80K 
53: R39         Derivative Instruments and Hedging Activities       HTML    104K 
                (Tables)                                                         
54: R40         Long-term Employee Benefits (Tables)                HTML    179K 
55: R41         Accumulated Other Comprehensive (Loss) Income       HTML     64K 
                (Tables)                                                         
56: R42         Summary of Significant Accounting Policies          HTML     91K 
                (Details)                                                        
57: R43         Business Combination - Narrative (Details)          HTML     77K 
58: R44         Business Combination - Purchase Price by Exchange   HTML     64K 
                Ratio (Details)                                                  
59: R45         Business Combination - Summary of Purchase Price    HTML    127K 
                (Details)                                                        
60: R46         Business Combination - Goodwill Allocation          HTML     53K 
                (Details)                                                        
61: R47         Business Combination - Purchase Price Allocation    HTML     47K 
                of Intangible Assets (Details)                                   
62: R48         Business Combination - Pro Forma Information        HTML     40K 
                (Details)                                                        
63: R49         Computation of Earnings Per Share - Calculation of  HTML     46K 
                Basic and Diluted Earnings Per Share (Details)                   
64: R50         Computation of Earnings Per Share - Narrative       HTML     39K 
                (Details)                                                        
65: R51         Revenue - Narrative (Details)                       HTML     90K 
66: R52         Revenue - Disaggregation of Revenue (Details)       HTML     53K 
67: R53         Revenue - Concentrations of Revenue and Credit      HTML     45K 
                Risk (Details)                                                   
68: R54         Segment and Geographic Information - Narrative      HTML     36K 
                (Details)                                                        
69: R55         Segment and Geographic Information - Total          HTML     52K 
                Revenues by Reportable Segment (Details)                         
70: R56         Segment and Geographic Information -                HTML     82K 
                Reconciliation to Income (Details)                               
71: R57         Segment and Geographic Information - Geographic     HTML     47K 
                Territory (Details)                                              
72: R58         Income Taxes - Components of (Benefit) Provision    HTML     62K 
                for Income Taxes (Detail)                                        
73: R59         Income Taxes - Schedule of Income before (Benefit)  HTML     43K 
                Provision for Income Taxes (Detail)                              
74: R60         Income Taxes - Schedule of Deferred Tax Assets and  HTML     73K 
                Liabilities (Detail)                                             
75: R61         Income Taxes - Narrative (Detail)                   HTML     84K 
76: R62         Income Taxes - Reconciliation of Income Tax         HTML     63K 
                Computed at Federal Statutory Rate (Detail)                      
77: R63         Income Taxes - Summary of Unrecognized Tax          HTML     49K 
                Benefits (Detail)                                                
78: R64         Income Taxes - Rollforward of Valuation Allowance   HTML     42K 
                (Details)                                                        
79: R65         Balance Sheet Account Details Cash, Cash            HTML     43K 
                Equivalents and Restricted Cash (Details)                        
80: R66         Balance Sheet Account Details Marketable            HTML     68K 
                Securities (Details)                                             
81: R67         Balance Sheet Account Details Accounts Receivable   HTML     42K 
                (Details)                                                        
82: R68         Balance Sheet Account Details - Narrative           HTML     43K 
                (Details)                                                        
83: R69         Balance Sheet Account Details - Accounts            HTML     45K 
                Receivable Allowance for Credit Loss Rollforward                 
                (Details)                                                        
84: R70         Balance Sheet Account Details Inventory (Details)   HTML     47K 
85: R71         Balance Sheet Account Details Prepaid expenses and  HTML     50K 
                other current assets (Details)                                   
86: R72         Balance Sheet Account Details - Property, Plant     HTML     53K 
                and Equipment (Details)                                          
87: R73         Balance Sheet Account Details - Goodwill            HTML     73K 
                Rollforward (Details)                                            
88: R74         Balance Sheet Account Details - Goodwill and        HTML     58K 
                Intangible Assets (Details)                                      
89: R75         Balance Sheet Account Details - Schedule of Future  HTML     45K 
                Amortization Expense (Details)                                   
90: R76         Balance Sheet Account Details Other Current         HTML     54K 
                Liabilities (Details)                                            
91: R77         Borrowings - Schedule of Borrowings (Details)       HTML     65K 
92: R78         Borrowings - Narrative (Details)                    HTML     86K 
93: R79         Borrowings - Interest Expense (Details)             HTML     57K 
94: R80         Borrowings - Schedule of Maturities (Details)       HTML     51K 
95: R81         Leases - Narrative (Detail)                         HTML     40K 
96: R82         Leases - Components of Lease Expense and            HTML     47K 
                Supplemental Cash Flow Information (Details)                     
97: R83         Leases - Commitments for Minimum Rentals under      HTML     66K 
                Non-cancelable Leases (Detail)                                   
98: R84         Stockholders' Equity (Details)                      HTML    130K 
99: R85         Stock-Based Compensation - Compensation Expense     HTML     48K 
                Related to Stock-Based Compensation Plans                        
                (Details)                                                        
100: R86         Stock-Based Compensation - Narrative (Details)      HTML     80K  
101: R87         Stock-Based Compensation - Summary of Status of     HTML     82K  
                Stock Option Activity (Details)                                  
102: R88         Stock-Based Compensation - Estimated Fair Value of  HTML     45K  
                Each Stock Option Award (Details)                                
103: R89         Stock-Based Compensation - Summary of Status of     HTML     57K  
                Stock Awards Activity (Details)                                  
104: R90         Commitments and Contingencies (Details)             HTML     38K  
105: R91         Fair Value Measurements - Assets and Liabilities    HTML     85K  
                Measured at Fair Value on Recurring Basis                        
                (Details)                                                        
106: R92         Fair Value Measurements - Narrative (Details)       HTML     42K  
107: R93         Derivative Instruments and Hedging Activities -     HTML     50K  
                Narrative (Details)                                              
108: R94         Derivative Instruments and Hedging Activities -     HTML     50K  
                Schedule of Interest Rate Derivative Agreements                  
                (Details)                                                        
109: R95         Derivative Instruments and Hedging Activities -     HTML     40K  
                Hedge Description (Details)                                      
110: R96         Derivative Instruments and Hedging Activities -     HTML     49K  
                Schedule of Gain (Loss) (Details)                                
111: R97         Derivative Instruments and Hedging Activities -     HTML     43K  
                Schedule of Net Investment Hedge (Details)                       
112: R98         Derivative Instruments and Hedging Activities -     HTML     55K  
                Schedule of Fair Value (Details)                                 
113: R99         Long-term Employee Benefits - Narrative (Details)   HTML     62K  
114: R100        Long-term Employee Benefits - Projected Benefit     HTML     99K  
                Obligations (Details)                                            
115: R101        Long-term Employee Benefits - Accumulated Benefit   HTML     52K  
                Obligation (Details)                                             
116: R102        Long-term Employee Benefits - Schedule of AOCI      HTML     43K  
                (Details)                                                        
117: R103        Long-term Employee Benefits - Critical Assumptions  HTML     50K  
                Used (Details)                                                   
118: R104        Long-term Employee Benefits - Schedule of Health    HTML     44K  
                Care Trend Rates (Details)                                       
119: R105        Long-term Employee Benefits - Expected Benefit      HTML     51K  
                Payments (Details)                                               
120: R106        Long-term Employee Benefits - Fair Value            HTML     95K  
                Measurement (Details)                                            
121: R107        Long-term Employee Benefits - Level 3 Rollforward   HTML     44K  
                (Details)                                                        
122: R108        Accumulated Other Comprehensive (Loss) Income       HTML     79K  
                (Details)                                                        
124: XML         IDEA XML File -- Filing Summary                      XML    231K  
127: XML         XBRL Instance -- qdel-20231231_htm                   XML   3.41M  
123: EXCEL       IDEA Workbook of Financial Report Info              XLSX    252K  
11: EX-101.CAL  XBRL Calculations -- qdel-20231231_cal               XML    351K 
12: EX-101.DEF  XBRL Definitions -- qdel-20231231_def                XML   1.17M 
13: EX-101.LAB  XBRL Labels -- qdel-20231231_lab                     XML   3.06M 
14: EX-101.PRE  XBRL Presentations -- qdel-20231231_pre              XML   1.88M 
10: EX-101.SCH  XBRL Schema -- qdel-20231231                         XSD    275K 
125: JSON        XBRL Instance as JSON Data -- MetaLinks              822±  1.24M  
126: ZIP         XBRL Zipped Folder -- 0001906324-24-000011-xbrl      Zip    798K  


‘EX-97.1’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 97.1
QuidelOrtho Corporation

Amended and Restated
Clawback Policy
1.PURPOSE
QuidelOrtho Corporation (the “Company”) is committed to conducting business with integrity, in accordance with high ethical standards and in compliance with all applicable laws, rules and regulations, including those regarding the presentation of the Company’s financial information to the public. As a result, the Board of Directors of the Company (the “Board”) has adopted this Clawback Policy (as amended from time to time, this “Policy”) effective as of the Effective Date. This Policy replaces in its entirety the Company’s prior Clawback Policy dated May 27, 2022 (the “Prior Policy”). Notwithstanding the foregoing, this Policy shall not affect any remedies or rights of recoupment that may become available to the Company under the Prior Policy with respect to any incentive compensation (or any portion thereof) that (i) was made, granted or Received prior to the Effective Date and (ii) is not recoverable under this Policy.
2.ADMINISTRATION
This Policy is administered by the Compensation Committee of the Board (the “Committee”) and is intended to comply with, and as applicable to be administered and interpreted consistent with, Listing Rule 5608 adopted by the Nasdaq Stock Market to implement Rule 10D-1 under the Securities Exchange Act of 1934, as amended (collectively, “Rule 10D-1”). Except as limited by law, the Committee has full power and authority to apply this Policy. Any determinations made by the Committee will be final, conclusive and binding on all affected individuals.
The Board or Committee may amend, modify or terminate this Policy in whole or in part at any time in its sole discretion and may adopt such rules and procedures that it deems necessary or appropriate to implement this Policy or to comply with applicable laws and regulations.
3.CLAWBACK TRIGGERS
In the event that the Company is required to prepare an accounting restatement of its financial statements due to the Company’s material noncompliance with any financial reporting requirement under the securities laws (including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (other than corrections resulting from changes to accounting standards)), the Company will recover on a reasonably prompt basis the amount of any Incentive-Based Compensation Received by a Covered Executive during the Recovery Period that exceeds the amount that otherwise would have been Received based upon the restated financial statements.
If the Committee determines the amount of Incentive-Based Compensation Received by a Covered Executive during a Recovery Period exceeds the amount that would have been Received if determined or calculated based on the Company’s restated financial results, such excess amount of Incentive-Based Compensation shall be subject to recoupment by the Company pursuant to this Policy. For Incentive-Based Compensation based on stock price or total shareholder return, the Committee will determine the amount based on a reasonable estimate of the effect of the accounting restatement on the relevant stock price or total shareholder return. In all cases, the calculation of the excess amount of Incentive-Based Compensation to be recovered will be determined on a pre-tax basis.
The Company shall enforce any recovery pursuant to this Policy by requiring payment of such amount(s) to the Company, by set-off, by reducing future compensation, or by all legal means or combination of means available as the Committee determines appropriate. Any right of recoupment or
1


recovery under this Policy shall apply irrespective of whether the Covered Executive is an employee of the Company at such time. The Company need not recover the excess amount of Incentive-Based Compensation if and to the extent that the Committee determines that such recovery is impracticable and not required under Rule 10D-1, including if the Committee determines that the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount to be recovered after making a reasonable attempt to recover such amounts, or recovery would impact the qualified status of a tax-qualified retirement plan. No recovery of compensation under this Policy will be an event giving rise to a right to resign for “good reason” or be deemed a “constructive termination” (or any similar term) as such terms are used in any agreement between any Covered Executive and the Company.
4.DEFINITIONS
1.     “Covered Executives” means any executive officer of the Company as defined in accordance with Rule 10D-1 under the Securities Exchange Act of 1934, as amended.
2.     “Financial Reporting Measure” is (i) any measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements and any measure derived wholly or in part from such a measure, and (ii) any measure based in whole or in part on the Company’s stock price or total shareholder return.
3.    “Incentive-Based Compensation” means any compensation that is granted, earned or vested based wholly or in part on the Company’s attainment of any Financial Reporting Measure, including annual bonuses and other short- and long-term cash, equity and equity-based incentive awards, that was Received by a person (i) on or after October 2, 2023 and after the person began service as a Covered Executive, and (ii) who served as a Covered Executive at any time during the performance period for the Incentive-Based Compensation. Incentive-Based Compensation is deemed to be “Received” in the fiscal period during which the relevant financial reporting measure is attained, regardless of when the compensation is actually paid or awarded.
4.    “Recovery Period” means the three completed fiscal years immediately preceding the date that the Company is required to prepare the accounting restatement described in this Policy and any “transition period” as prescribed under Rule 10D-1.
5.NOT EXCLUSIVE
Any right of recoupment or recovery under this Policy is in addition to, and not in lieu of, any other remedies or rights that may be available to the Company, including (i) pursuant to the terms of any Company plan or policy or any agreement with the Covered Executive, (ii) disciplinary action up to and including termination, and (iii) any other legal remedies available to the Company (including Section 304 of the Sarbanes-Oxley Act of 2002); provided that the Company shall not recoup amounts pursuant to such other plan, policy, agreement, remedies or rights to the extent it is recovered pursuant to this Policy).
6.NO INDEMNIFICATION
The Company will not indemnify any Covered Executive against any loss pursuant to this Policy, nor will the Company pay or agree to pay any insurance premium to cover any loss hereunder.

Effective Date: October 2, 2023
2

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/29/24
For Period end:12/31/23
10/2/23
5/27/223,  4,  4/A,  8-K12B,  8-K12B/A
 List all Filings 


14 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/01/23  QuidelOrtho Corp.                 8-K:5,9    11/27/23   12:279K
 5/04/23  QuidelOrtho Corp.                 10-Q        4/02/23   77:6.9M
 2/23/23  QuidelOrtho Corp.                 10-K        1/01/23  123:15M
12/13/22  QuidelOrtho Corp.                 8-K:5,9    12/08/22   13:508K
 8/05/22  QuidelOrtho Corp.                 10-Q        7/03/22   88:9.6M
 5/27/22  QuidelOrtho Corp.                 8-K12B:1,2, 5/27/22   19:2M                                     Donnelley … Solutions/FA
 2/04/22  Quidel Corp./DE                   8-K:5,9     1/31/22   15:253K
 1/31/22  QuidelOrtho Corp.                 S-4                    6:6.7M                                   Donnelley … Solutions/FA
 1/18/22  Ortho Clinical Diagnostics H… plc 8-K:5,9     1/11/22   11:246K                                   Donnelley … Solutions/FA
12/23/21  Quidel Corp./DE                   8-K:1,7,9  12/22/21   13:1.1M                                   Donnelley … Solutions/FA
 7/26/21  Quidel Corp./DE                   8-K:1,7,9   7/24/21   12:443K                                   Donnelley … Solutions/FA
 1/09/18  Quidel Corp./DE                   8-K:1,2,8,9 1/05/18    3:1.4M
 1/20/09  Quidel Corp./DE                   8-K:1,5,9   1/16/09    7:428K                                   Toppan Merrill/FA
 6/06/08  Quidel Corp./DE                   8-K:1,5,9   6/05/08    3:142K                                   Toppan Merrill/FA
Top
Filing Submission 0001906324-24-000011   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 7:24:48.3am ET